Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases

Krumme D, Wenzel H, Tschesche H (1998)
FEBS LETTERS 436(2): 209-212.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Abstract / Bemerkung
Novel peptides containing the sequence -Pro-Leu-Ama(NHOH)- were synthesized and characterized by spectroscopic techniques. Their inhibitory properties towards the activated form of native human gelatinase B (MMP-9) and the catalytic domain of neutrophil collagenase (cdMMP-8) were determined. The most effective inhibitor synthesized exhibits K-i values of 2 x 10(-6) Il I (cdMMP-8) and 5 x 10(-9) RI (MMP-9) thus attaining interesting discrimination between the tested metalloproteinases. A most important feature of this type of inhibitor is its peptide nature making the compounds similar to natural substrates. In spite of the peptide character of the inhibitors synthesized, the P-1-P-1'-peptide bond shows a high resistance to cleavage by the proteinases. (C) 1998 Federation of European Biochemical Societies.
Erscheinungsjahr
Zeitschriftentitel
FEBS LETTERS
Band
436
Zeitschriftennummer
2
Seite
209-212
ISSN
PUB-ID

Zitieren

Krumme D, Wenzel H, Tschesche H. Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases. FEBS LETTERS. 1998;436(2):209-212.
Krumme, D., Wenzel, H., & Tschesche, H. (1998). Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases. FEBS LETTERS, 436(2), 209-212. doi:10.1016/S0014-5793(98)01128-4
Krumme, D., Wenzel, H., and Tschesche, H. (1998). Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases. FEBS LETTERS 436, 209-212.
Krumme, D., Wenzel, H., & Tschesche, H., 1998. Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases. FEBS LETTERS, 436(2), p 209-212.
D. Krumme, H. Wenzel, and H. Tschesche, “Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases”, FEBS LETTERS, vol. 436, 1998, pp. 209-212.
Krumme, D., Wenzel, H., Tschesche, H.: Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases. FEBS LETTERS. 436, 209-212 (1998).
Krumme, D, Wenzel, Herbert, and Tschesche, Harald. “Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases”. FEBS LETTERS 436.2 (1998): 209-212.

11 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Novel biodegradable, biomimetic and functionalised polymer scaffolds to prevent expansion of post-infarct left ventricular remodelling.
Cristallini C, Gagliardi M, Barbani N, Giannessi D, Guerra GD., J Mater Sci Mater Med 23(1), 2012
PMID: 22143909
Rational design of tropoelastin peptide-based inhibitors of metalloproteinases.
Jensen SA, Andersen P, Vrhovski B, Weiss AS., Arch Biochem Biophys 409(2), 2003
PMID: 12504900
General synthesis of alpha-substituted 3-bisaryloxy propionic acid derivatives as specific MMP inhibitors.
Chollet AM, Le Diguarher T, Murray L, Bertrand M, Tucker GC, Sabatini M, Pierré A, Atassi G, Bonnet J, Casara P., Bioorg Med Chem Lett 11(3), 2001
PMID: 11212095
Determination of matrix metalloproteinase activity using biotinylated gelatin.
Ratnikov B, Deryugina E, Leng J, Marchenko G, Dembrow D, Strongin A., Anal Biochem 286(1), 2000
PMID: 11038285

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 9781680
PubMed | Europe PMC

Suchen in

Google Scholar